396 is the total number of securities Eversept Partners, LP has owned. The longest Eversept Partners, LP has owned a single stock is 21 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
AMRN | AMARIN CORP PLC | 19 | 2 | 0.35% | 4.80% | 12.48% | Q1 2018 | Q3 2023 | 21 |
DHR | DANAHER CORPORATION | 21 | 21 | 1.50% | 3.79% | 8.06% | Q3 2018 | Q3 2023 | 21 |
AFMD | AFFIMED N V | 14 | 6 | 0.04% | 0.38% | 0.94% | Q1 2018 | Q3 2023 | 20 |
ARGX | ARGENX SE | 9 | 1 | 0.10% | 0.82% | 1.99% | Q4 2017 | Q3 2023 | 19 |
GSK | GSK PLC | 18 | 18 | 0.31% | 5.00% | 13.13% | Q1 2018 | Q2 2022 | 18 |
ASND | ASCENDIS PHARMA A/S | 18 | 18 | 0.28% | 3.43% | 7.71% | Q4 2017 | Q1 2022 | 18 |
SNY | SANOFI | 13 | 2 | 0.12% | 3.13% | 7.20% | Q4 2017 | Q4 2022 | 18 |
ENSG | ENSIGN GROUP INC | 18 | 18 | 0.05% | 2.69% | 8.64% | Q4 2017 | Q1 2022 | 18 |
CNC | CENTENE CORP DEL | 11 | 1 | 0.27% | 0.81% | 1.54% | Q1 2018 | Q3 2023 | 18 |
ZGNX | ZOGENIX INC | 17 | 17 | 0.57% | 4.98% | 12.38% | Q4 2017 | Q4 2021 | 17 |
FATE | FATE THERAPEUTICS INC | 17 | 17 | 0.04% | 1.66% | 4.75% | Q4 2018 | Q4 2022 | 17 |
BCRX | BIOCRYST PHARMACEUTICA... | 13 | 4 | 0.33% | 1.30% | 3.75% | Q4 2017 | Q3 2023 | 17 |
HSKA | HESKA CORP | 17 | 17 | 0.04% | 0.69% | 3.58% | Q1 2019 | Q1 2023 | 17 |
CYH | COMMUNITY HEALTH SYS I... | 12 | 4 | 0.01% | 2.31% | 6.50% | Q3 2019 | Q3 2023 | 16 |
ANTM | ELEVANCE HEALTH INC | 8 | 1 | 0.09% | 0.89% | 2.48% | Q1 2018 | Q3 2023 | 16 |
TARO | TARO PHARMACEUTICAL IN... | 16 | 16 | 0.08% | 0.80% | 1.73% | Q4 2019 | Q3 2023 | 16 |
APLS | APELLIS PHARMACEUTICAL... | 12 | 1 | 0.03% | 1.08% | 5.99% | Q2 2018 | Q3 2023 | 15 |
PBYI | PUMA BIOTECHNOLOGY INC | 9 | 1 | 0.12% | 0.58% | 3.11% | Q4 2017 | Q3 2023 | 15 |
LQDA | LIQUIDIA TECHNOLOGIES INC | 11 | 4 | 0.10% | 0.47% | 0.99% | Q4 2019 | Q3 2023 | 15 |
SPY | SPDR S&P 500 ETF TR TR | 4 | 1 | 2.98% | 8.44% | 14.38% | Q4 2017 | Q3 2023 | 14 |
HZNP | HORIZON THERAPEUTICS P... | 14 | 14 | 2.02% | 5.83% | 10.61% | Q2 2020 | Q3 2023 | 14 |
UTHR | UNITED THERAPEUTICS CO... | 14 | 14 | 3.47% | 5.21% | 8.17% | Q2 2020 | Q3 2023 | 14 |
TGTX | TG THERAPEUTICS INC | 14 | 14 | 0.14% | 2.54% | 6.68% | Q1 2018 | Q2 2021 | 14 |
AMRX | AMNEAL PHARMACEUTICALS... | 14 | 14 | 0.14% | 1.37% | 2.54% | Q2 2020 | Q3 2023 | 14 |
XENE | XENON PHARMACEUTICALS INC | 7 | 7 | 0.20% | 0.69% | 1.22% | Q3 2018 | Q2 2023 | 14 |
RCM | R1 RCM INC | 9 | 4 | 0.96% | 4.80% | 10.11% | Q4 2017 | Q1 2022 | 13 |
TEVA | TEVA PHARMACEUTICAL IN... | 13 | 13 | 1.18% | 3.42% | 6.00% | Q3 2020 | Q3 2023 | 13 |
RDUS | RADIUS HEALTH INC | 11 | 2 | 0.20% | 3.00% | 6.32% | Q4 2017 | Q2 2022 | 13 |
NTRA | NATERA INC | 6 | 1 | 0.07% | 4.11% | 10.92% | Q4 2018 | Q3 2023 | 12 |
NVST | ENVISTA HOLDINGS CORPO... | 9 | 3 | 0.41% | 2.15% | 3.41% | Q3 2019 | Q4 2022 | 12 |
DCPH | DECIPHERA PHARMACEUTIC... | 10 | 2 | 0.17% | 1.84% | 4.59% | Q1 2018 | Q1 2021 | 12 |
HCA | HCA HEALTHCARE INC | 9 | 3 | 0.12% | 1.18% | 2.29% | Q1 2020 | Q3 2023 | 12 |
HUM | HUMANA INC | 6 | 1 | 0.32% | 0.68% | 1.04% | Q2 2019 | Q3 2023 | 12 |
IQV | IQVIA HLDGS INC | 12 | 12 | 0.09% | 0.27% | 1.06% | Q4 2020 | Q3 2023 | 12 |
A | AGILENT TECHNOLOGIES INC | 12 | 12 | 0.07% | 0.19% | 0.40% | Q4 2020 | Q3 2023 | 12 |
AZN | ASTRAZENECA PLC | 11 | 11 | 0.74% | 3.50% | 5.00% | Q4 2019 | Q2 2022 | 11 |
AVTR | AVANTOR INC | 10 | 1 | 0.13% | 1.97% | 3.67% | Q4 2020 | Q3 2023 | 11 |
ILMN | ILLUMINA INC | 7 | 1 | 0.46% | 1.70% | 2.76% | Q4 2018 | Q3 2023 | 11 |
QGEN | QIAGEN NV | 9 | 1 | 0.48% | 1.14% | 2.10% | Q4 2018 | Q2 2022 | 11 |
DXCM | DEXCOM INC | 7 | 4 | 0.08% | 0.61% | 2.06% | Q3 2019 | Q2 2022 | 11 |
RGEN | REPLIGEN CORP | 11 | 11 | 0.02% | 0.25% | 0.84% | Q1 2021 | Q3 2023 | 11 |
VRTX | VERTEX PHARMACEUTICALS... | 9 | 1 | 0.73% | 2.97% | 5.01% | Q4 2017 | Q2 2021 | 10 |
TLGT | TELIGENT INC NEW | 10 | 10 | 0.27% | 1.78% | 3.66% | Q4 2017 | Q1 2020 | 10 |
ALNY | ALNYLAM PHARMACEUTICAL... | 6 | 2 | 0.58% | 1.57% | 4.36% | Q1 2018 | Q2 2022 | 10 |
CLDX | CELLDEX THERAPEUTICS I... | 8 | 2 | 0.50% | 1.50% | 2.23% | Q2 2020 | Q3 2023 | 10 |
EHTH | EHEALTH INC | 5 | 2 | 0.11% | 1.50% | 4.31% | Q4 2017 | Q2 2023 | 10 |
MODN | MODEL N INC | 5 | 2 | 0.19% | 1.02% | 2.07% | Q2 2018 | Q2 2023 | 10 |
IONS | IONIS PHARMACEUTICALS INC | 10 | 10 | 0.23% | 0.78% | 1.18% | Q2 2021 | Q3 2023 | 10 |
GH | GUARDANT HEALTH INC | 9 | 1 | 0.02% | 0.71% | 1.16% | Q4 2019 | Q1 2023 | 10 |
ALBO | ALBIREO PHARMA INC | 10 | 10 | 0.11% | 0.25% | 0.35% | Q1 2018 | Q2 2020 | 10 |
BHVN | BIOHAVEN PHARMACTL HLD... | 5 | 4 | 0.90% | 3.99% | 8.35% | Q1 2020 | Q3 2022 | 9 |
SRPT | SAREPTA THERAPEUTICS INC | 5 | 1 | 0.06% | 1.95% | 2.99% | Q2 2018 | Q4 2020 | 9 |
ABMD | ABIOMED INC | 6 | 1 | 0.68% | 1.37% | 2.45% | Q4 2017 | Q3 2022 | 9 |
ICLR | ICON PLC | 9 | 9 | 0.09% | 0.85% | 1.50% | Q3 2021 | Q3 2023 | 9 |
CTRE | CARETRUST REIT INC | 9 | 9 | 0.28% | 0.65% | 1.35% | Q4 2017 | Q4 2019 | 9 |
DRNA | DICERNA PHARMACEUTICAL... | 9 | 9 | 0.07% | 0.27% | 0.48% | Q2 2018 | Q2 2020 | 9 |
MRUS | MERUS N V | 8 | 1 | 0.03% | 0.24% | 0.48% | Q4 2020 | Q3 2023 | 9 |
PKI | REVVITY INC | 9 | 9 | 0.10% | 0.23% | 0.57% | Q3 2021 | Q3 2023 | 9 |
GOSS | GOSSAMER BIO INC | 9 | 9 | 0.03% | 0.20% | 0.57% | Q3 2021 | Q3 2023 | 9 |
ACIU | AC IMMUNE SA | 9 | 9 | 0.02% | 0.04% | 0.10% | Q3 2021 | Q3 2023 | 9 |
QQQ | INVESCO QQQ TR | 4 | 1 | 5.01% | 9.34% | 18.11% | Q2 2021 | Q3 2023 | 8 |
MCRB | SERES THERAPEUTICS INC | 5 | 3 | 0.10% | 0.78% | 1.23% | Q4 2020 | Q3 2023 | 8 |
MYOK | MYOKARDIA INC | 3 | 2 | 0.28% | 0.70% | 1.21% | Q4 2017 | Q2 2020 | 8 |
MGLN | MAGELLAN HEALTH INC | 5 | 3 | 0.13% | 0.60% | 1.02% | Q4 2017 | Q4 2021 | 8 |
IVC | INVACARE CORP | 8 | 8 | 0.17% | 0.53% | 0.94% | Q4 2017 | Q3 2019 | 8 |
OTIC | OTONOMY INC | 8 | 8 | 0.14% | 0.26% | 0.37% | Q1 2019 | Q4 2020 | 8 |
AERI | AERIE PHARMACEUTICALS INC | 6 | 1 | 0.34% | 4.34% | 8.30% | Q4 2017 | Q3 2022 | 7 |
GSK | GSK PLC | 7 | 7 | 1.52% | 3.80% | 5.20% | Q4 2020 | Q2 2022 | 7 |
CTLT | CATALENT INC | 3 | 1 | 1.29% | 2.25% | 3.41% | Q3 2020 | Q2 2023 | 7 |
AMRN | AMARIN CORP PLC | 7 | 7 | 0.21% | 1.24% | 3.76% | Q3 2019 | Q1 2021 | 7 |
ITCI | INTRA-CELLULAR THERAPI... | 6 | 1 | 0.32% | 0.80% | 1.33% | Q3 2020 | Q1 2023 | 7 |
ANAB | ANAPTYSBIO INC | 4 | 1 | 0.15% | 0.47% | 1.06% | Q2 2018 | Q2 2022 | 7 |
MRK | MERCK & CO INC | 7 | 7 | 0.24% | 0.31% | 0.47% | Q2 2021 | Q4 2022 | 7 |
TEVA | TEVA PHARMACEUTICAL IN... | 7 | 7 | 0.05% | 0.26% | 0.65% | Q2 2021 | Q4 2022 | 7 |
AUTL | AUTOLUS THERAPEUTICS PLC | 4 | 1 | 0.12% | 0.24% | 0.57% | Q1 2020 | Q1 2022 | 7 |
ISRG | INTUITIVE SURGICAL INC | 7 | 7 | 0.12% | 0.17% | 0.23% | Q1 2021 | Q3 2022 | 7 |
AADI BIOSCIENCE INC | 7 | 7 | 0.04% | 0.10% | 0.20% | Q1 2022 | Q3 2023 | 7 | |
SNDX | SYNDAX PHARMACEUTICALS... | 6 | 6 | 1.36% | 2.96% | 3.83% | Q2 2022 | Q3 2023 | 6 |
ARRY | ARRAY BIOPHARMA INC | 6 | 6 | 0.37% | 2.47% | 9.12% | Q4 2017 | Q1 2019 | 6 |
ARNA | ARENA PHARMACEUTICALS INC | 6 | 6 | 0.99% | 2.18% | 4.05% | Q1 2018 | Q2 2019 | 6 |
BIIB | BIOGEN INC | 6 | 6 | 0.51% | 1.82% | 3.33% | Q4 2021 | Q1 2023 | 6 |
HQY | HEALTHEQUITY INC | 5 | 1 | 0.51% | 0.98% | 2.09% | Q2 2021 | Q3 2023 | 6 |
ARQL | ARQULE INC | 6 | 6 | 0.52% | 0.90% | 1.39% | Q2 2018 | Q3 2019 | 6 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 6 | 6 | 0.40% | 0.79% | 1.32% | Q3 2019 | Q4 2020 | 6 |
PNTG | PENNANT GROUP INC | 3 | 3 | 0.32% | 0.78% | 2.17% | Q4 2019 | Q3 2023 | 6 |
MDCO | MEDICINES CO | 3 | 1 | 0.22% | 0.73% | 1.72% | Q1 2018 | Q4 2019 | 6 |
MRVI | MARAVAI LIFESCIENCES H... | 3 | 1 | 0.21% | 0.53% | 1.12% | Q2 2021 | Q3 2023 | 6 |
VRDN | VIRIDIAN THERAPEUTICS INC | 5 | 1 | 0.18% | 0.41% | 0.85% | Q3 2021 | Q3 2023 | 6 |
FOMX | FOAMIX PHARMACEUTICALS... | 6 | 6 | 0.18% | 0.38% | 0.69% | Q1 2018 | Q2 2019 | 6 |
SCPH | SCPHARMACEUTICALS INC | 6 | 6 | 0.11% | 0.24% | 0.40% | Q2 2019 | Q3 2020 | 6 |
EIGR | EIGER BIOPHARMACEUTICA... | 6 | 6 | 0.06% | 0.18% | 0.28% | Q1 2019 | Q2 2020 | 6 |
XOMA | XOMA CORP DEL | 5 | 1 | 0.11% | 0.14% | 0.17% | Q2 2020 | Q3 2023 | 6 |
CYCN | CYCLERION THERAPEUTICS... | 3 | 1 | 0.03% | 0.11% | 0.22% | Q2 2019 | Q1 2022 | 6 |
ELDN | ELEDON PHARMACEUTICALS... | 6 | 6 | 0.01% | 0.03% | 0.05% | Q3 2021 | Q4 2022 | 6 |
GSK PLC | 5 | 5 | 7.56% | 9.28% | 10.84% | Q3 2022 | Q3 2023 | 5 | |
ARKG | ARK ETF TR | 5 | 5 | 1.66% | 3.60% | 5.38% | Q1 2021 | Q1 2022 | 5 |
MCK | MCKESSON CORP | 5 | 5 | 0.96% | 1.68% | 2.24% | Q1 2021 | Q1 2022 | 5 |
OCDX | ORTHO CLINICAL DIAGNOS... | 5 | 5 | 0.64% | 1.40% | 2.00% | Q1 2021 | Q1 2022 | 5 |
VERA | VERA THERAPEUTICS INC | 5 | 5 | 0.29% | 1.20% | 2.34% | Q3 2022 | Q3 2023 | 5 |
TECH | BIO-TECHNE CORP | 4 | 1 | 0.04% | 1.14% | 2.34% | Q1 2022 | Q3 2023 | 5 |
XBI | SPDR SER TR | 3 | 1 | 0.62% | 1.05% | 1.80% | Q2 2021 | Q4 2022 | 5 |
LH | LABORATORY CORP AMER H... | 5 | 5 | 0.09% | 0.88% | 2.51% | Q3 2021 | Q3 2022 | 5 |
KDMN | KADMON HLDGS INC | 3 | 2 | 0.23% | 0.75% | 1.17% | Q4 2019 | Q2 2021 | 5 |
TCDA | TRICIDA INC | 5 | 5 | 0.32% | 0.60% | 0.97% | Q3 2018 | Q3 2019 | 5 |
BDSI | BIODELIVERY SCIENCES I... | 5 | 5 | 0.12% | 0.45% | 0.92% | Q2 2019 | Q2 2020 | 5 |
CYH | COMMUNITY HEALTH SYS I... | 3 | 2 | 0.05% | 0.44% | 1.09% | Q3 2021 | Q4 2022 | 5 |
DERM | DERMIRA INC | 3 | 2 | 0.07% | 0.43% | 1.07% | Q1 2018 | Q2 2019 | 5 |
CBAY | CYMABAY THERAPEUTICS INC | 5 | 5 | 0.17% | 0.36% | 0.66% | Q2 2018 | Q2 2019 | 5 |
IFRX | INFLARX NV | 2 | 1 | 0.08% | 0.33% | 0.71% | Q4 2019 | Q3 2023 | 5 |
SESN | SESEN BIO INC | 5 | 5 | 0.18% | 0.27% | 0.48% | Q4 2019 | Q4 2020 | 5 |
SRGA | SURGALIGN HOLDINGS INC | 5 | 5 | 0.04% | 0.23% | 0.43% | Q1 2021 | Q1 2022 | 5 |
IMVT | IMMUNOVANT INC | 3 | 2 | 0.04% | 0.18% | 0.30% | Q4 2019 | Q2 2021 | 5 |
SPNE | SEASPINE HLDGS CORP | 5 | 5 | 0.15% | 0.17% | 0.21% | Q4 2017 | Q4 2018 | 5 |
GOCO | GOHEALTH INC | 5 | 5 | 0.04% | 0.13% | 0.44% | Q3 2020 | Q3 2021 | 5 |
PFNX | PFENEX INC | 5 | 5 | 0.09% | 0.12% | 0.15% | Q1 2019 | Q1 2020 | 5 |
AQXP | AQUINOX PHARMACEUTICAL... | 3 | 2 | 0.05% | 0.11% | 0.21% | Q4 2017 | Q2 2019 | 5 |
TELIGENT INC NEW | 3 | 2 | 0.03% | 0.08% | 0.12% | Q2 2020 | Q3 2021 | 5 | |
MIST | MILESTONE PHARMACEUTIC... | 5 | 5 | 0.04% | 0.07% | 0.10% | Q3 2021 | Q3 2022 | 5 |
CSU | SONIDA SENIOR LIVING INC | 5 | 5 | 0.01% | 0.02% | 0.04% | Q4 2021 | Q4 2022 | 5 |
GLYC | GLYCOMIMETICS INC | 5 | 5 | 0.00% | 0.01% | 0.03% | Q4 2021 | Q4 2022 | 5 |
XLRN | ACCELERON PHARMA INC | 3 | 1 | 0.94% | 2.60% | 4.18% | Q1 2020 | Q3 2021 | 4 |
SAGE | SAGE THERAPEUTICS INC | 4 | 4 | 0.43% | 2.01% | 3.11% | Q1 2018 | Q4 2018 | 4 |
TSRO | TESARO INC | 3 | 1 | 1.07% | 1.99% | 4.09% | Q4 2017 | Q4 2018 | 4 |
AZN | ASTRAZENECA PLC | 4 | 4 | 1.08% | 1.89% | 2.92% | Q3 2021 | Q2 2022 | 4 |
NVRO | NEVRO CORP | 3 | 1 | 0.34% | 1.77% | 2.58% | Q4 2017 | Q4 2021 | 4 |
MRK | MERCK & CO INC | 2 | 2 | 0.15% | 1.75% | 4.63% | Q3 2018 | Q1 2022 | 4 |
VRTX | VERTEX PHARMACEUTICALS... | 4 | 4 | 0.97% | 1.70% | 2.33% | Q1 2021 | Q4 2021 | 4 |
ABT | ABBOTT LABS | 4 | 4 | 1.23% | 1.57% | 2.42% | Q1 2018 | Q4 2018 | 4 |
XBI | SPDR SER TR | 3 | 1 | 0.12% | 1.07% | 1.88% | Q2 2022 | Q3 2023 | 4 |
AUPH | AURINIA PHARMACEUTICAL... | 3 | 1 | 0.29% | 0.98% | 1.43% | Q2 2020 | Q4 2021 | 4 |
PCVX | VAXCYTE INC | 4 | 4 | 0.75% | 0.79% | 0.82% | Q4 2022 | Q3 2023 | 4 |
SWAV | SHOCKWAVE MED INC | 3 | 1 | 0.04% | 0.67% | 1.42% | Q2 2022 | Q3 2023 | 4 |
ARKK | ARK ETF TR | 4 | 4 | 0.27% | 0.62% | 0.74% | Q1 2021 | Q4 2021 | 4 |
XBI | SPDR SER TR | 3 | 1 | 0.42% | 0.61% | 0.90% | Q2 2021 | Q3 2023 | 4 |
CYTK | CYTOKINETICS INC | 4 | 4 | 0.34% | 0.49% | 0.64% | Q3 2019 | Q2 2020 | 4 |
EXEL | EXELIXIS INC | 4 | 4 | 0.22% | 0.49% | 0.76% | Q2 2021 | Q1 2022 | 4 |
MGNX | MACROGENICS INC | 4 | 4 | 0.13% | 0.47% | 0.91% | Q2 2019 | Q1 2020 | 4 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 3 | 1 | 0.22% | 0.43% | 0.67% | Q1 2018 | Q1 2020 | 4 |
ZGNX | ZOGENIX INC | 2 | 1 | 0.02% | 0.41% | 1.40% | Q2 2018 | Q2 2020 | 4 |
AMN | AMN HEALTHCARE SVCS INC | 3 | 1 | 0.17% | 0.41% | 0.87% | Q3 2022 | Q3 2023 | 4 |
EPZM | EPIZYME INC | 4 | 4 | 0.08% | 0.27% | 0.47% | Q1 2018 | Q4 2018 | 4 |
PRTA | PROTHENA CORP PLC | 4 | 4 | 0.13% | 0.27% | 0.44% | Q2 2020 | Q1 2021 | 4 |
BIOHAVEN LTD | 4 | 4 | 0.18% | 0.24% | 0.29% | Q4 2022 | Q3 2023 | 4 | |
CNCE | CONCERT PHARMACEUTICAL... | 3 | 1 | 0.15% | 0.22% | 0.32% | Q1 2019 | Q4 2020 | 4 |
OPHT | OPHTHOTECH CORP | 4 | 4 | 0.15% | 0.20% | 0.27% | Q4 2017 | Q3 2018 | 4 |
AKRXQ | AKORN INC | 3 | 1 | 0.01% | 0.19% | 0.53% | Q2 2018 | Q4 2019 | 4 |
LXRX | LEXICON PHARMACEUTICAL... | 4 | 4 | 0.07% | 0.19% | 0.29% | Q1 2021 | Q4 2021 | 4 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 3 | 1 | 0.12% | 0.18% | 0.28% | Q1 2018 | Q2 2020 | 4 |
AVTE | AEROVATE THERAPEUTICS INC | 4 | 4 | 0.06% | 0.11% | 0.23% | Q4 2022 | Q3 2023 | 4 |
QCP | QUALITY CARE PPTYS INC | 3 | 3 | 1.98% | 7.28% | 10.57% | Q4 2017 | Q2 2018 | 3 |
ALXN | ALEXION PHARMACEUTICAL... | 2 | 1 | 2.30% | 4.85% | 6.90% | Q4 2017 | Q1 2021 | 3 |
CCXI | CHEMOCENTRYX INC | 3 | 3 | 0.32% | 3.23% | 5.79% | Q4 2019 | Q2 2020 | 3 |
BMRN | BIOMARIN PHARMACEUTICA... | 3 | 3 | 1.73% | 2.57% | 3.63% | Q4 2017 | Q2 2018 | 3 |
BOLD | AUDENTES THERAPEUTICS INC | 3 | 3 | 1.69% | 2.38% | 3.23% | Q2 2019 | Q4 2019 | 3 |
BIIB | BIOGEN INC | 1 | 1 | 0.86% | 1.93% | 2.67% | Q2 2021 | Q3 2022 | 3 |
MASI | MASIMO CORP | 2 | 1 | 0.06% | 1.22% | 2.34% | Q3 2021 | Q2 2022 | 3 |
MNTA | MOMENTA PHARMACEUTICAL... | 3 | 3 | 0.57% | 0.90% | 1.15% | Q1 2020 | Q3 2020 | 3 |
FLDM | FLUIDIGM CORP DEL | 2 | 1 | 0.24% | 0.88% | 2.15% | Q4 2018 | Q3 2020 | 3 |
OHI | OMEGA HEALTHCARE INVS INC | 3 | 3 | 0.43% | 0.78% | 1.38% | Q2 2019 | Q4 2019 | 3 |
NSTG | NANOSTRING TECHNOLOGIE... | 3 | 3 | 0.56% | 0.68% | 0.75% | Q3 2021 | Q1 2022 | 3 |
LTC | LTC PPTYS INC | 3 | 3 | 0.42% | 0.66% | 1.10% | Q2 2019 | Q4 2019 | 3 |
SBRA | SABRA HEALTH CARE REIT... | 3 | 3 | 0.29% | 0.61% | 1.10% | Q2 2019 | Q4 2019 | 3 |
GBT | GLOBAL BLOOD THERAPEUT... | 3 | 3 | 0.28% | 0.52% | 0.88% | Q4 2017 | Q2 2018 | 3 |
COLL | COLLEGIUM PHARMACEUTIC... | 3 | 3 | 0.40% | 0.50% | 0.57% | Q2 2019 | Q4 2019 | 3 |
HZNP | HORIZON THERAPEUTICS P... | 3 | 3 | 0.44% | 0.48% | 0.53% | Q2 2021 | Q4 2021 | 3 |
QDEL | QUIDEL CORP | 3 | 3 | 0.04% | 0.45% | 0.86% | Q3 2020 | Q1 2021 | 3 |
IRTC | IRHYTHM TECHNOLOGIES INC | 3 | 3 | 0.33% | 0.45% | 0.55% | Q3 2021 | Q1 2022 | 3 |
NEWAMSTERDAM PHARMA CO... | 3 | 3 | 0.04% | 0.42% | 0.69% | Q1 2023 | Q3 2023 | 3 | |
PODD | INSULET CORP | 1 | 1 | 0.29% | 0.40% | 0.51% | Q3 2018 | Q3 2023 | 3 |
MASS | 908 DEVICES INC | 3 | 3 | 0.19% | 0.40% | 0.69% | Q1 2022 | Q3 2022 | 3 |
AGRX | AGILE THERAPEUTICS INC | 3 | 3 | 0.33% | 0.39% | 0.50% | Q3 2019 | Q1 2020 | 3 |
FOLD | AMICUS THERAPEUTICS INC | 2 | 1 | 0.33% | 0.37% | 0.42% | Q3 2018 | Q2 2022 | 3 |
IRMD | IRADIMED CORP | 3 | 3 | 0.17% | 0.32% | 0.44% | Q4 2017 | Q2 2018 | 3 |
ABUS | ARBUTUS BIOPHARMA CORP | 3 | 3 | 0.27% | 0.30% | 0.33% | Q4 2017 | Q2 2018 | 3 |
CVAC | CUREVAC N V | 2 | 1 | 0.19% | 0.27% | 0.31% | Q4 2021 | Q3 2023 | 3 |
ZNTL | ZENTALIS PHARMACEUTICA... | 3 | 3 | 0.08% | 0.26% | 0.36% | Q4 2021 | Q2 2022 | 3 |
EOLS | EVOLUS INC | 3 | 3 | 0.13% | 0.25% | 0.47% | Q4 2022 | Q2 2023 | 3 |
MEDP | MEDPACE HLDGS INC | 3 | 3 | 0.15% | 0.22% | 0.31% | Q1 2023 | Q3 2023 | 3 |
OPTN | OPTINOSE INC | 3 | 3 | 0.17% | 0.20% | 0.23% | Q2 2019 | Q4 2019 | 3 |
MLNT | MELINTA THERAPEUTICS INC | 3 | 3 | 0.05% | 0.18% | 0.26% | Q1 2018 | Q3 2018 | 3 |
KRTX | KARUNA THERAPEUTICS INC | 3 | 3 | 0.13% | 0.17% | 0.21% | Q3 2021 | Q1 2022 | 3 |
KALV | KALVISTA PHARMACEUTICA... | 3 | 3 | 0.04% | 0.16% | 0.30% | Q2 2020 | Q4 2020 | 3 |
TARA | PROTARA THERAPEUTICS INC | 3 | 3 | 0.10% | 0.14% | 0.19% | Q2 2020 | Q4 2020 | 3 |
NVAX | NOVAVAX INC | 3 | 3 | 0.14% | 0.14% | 0.14% | Q1 2021 | Q3 2021 | 3 |
GOHEALTH INC | 3 | 3 | 0.05% | 0.12% | 0.17% | Q4 2022 | Q2 2023 | 3 | |
CABA | CABALETTA BIO INC | 2 | 1 | 0.03% | 0.11% | 0.23% | Q1 2021 | Q4 2022 | 3 |
ACAD | ACADIA PHARMACEUTICALS... | 2 | 1 | 0.05% | 0.10% | 0.14% | Q1 2021 | Q4 2021 | 3 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 3 | 3 | 0.04% | 0.09% | 0.16% | Q3 2021 | Q1 2022 | 3 |
AVRO | AVROBIO INC | 3 | 3 | 0.03% | 0.08% | 0.14% | Q3 2021 | Q1 2022 | 3 |
FREQ | FREQUENCY THERAPEUTICS... | 3 | 3 | 0.03% | 0.08% | 0.14% | Q1 2021 | Q3 2021 | 3 |
MREO | MEREO BIOPHARMA GROUP PLC | 3 | 3 | 0.03% | 0.07% | 0.15% | Q3 2021 | Q1 2022 | 3 |
ASMB | ASSEMBLY BIOSCIENCES INC | 3 | 3 | 0.04% | 0.06% | 0.08% | Q3 2021 | Q1 2022 | 3 |
CFMS | CONFORMIS INC | 3 | 3 | 0.03% | 0.05% | 0.07% | Q2 2018 | Q4 2018 | 3 |
ORTX | ORCHARD THERAPEUTICS PLC | 3 | 3 | 0.02% | 0.05% | 0.09% | Q3 2021 | Q1 2022 | 3 |
FSTX | F-STAR THERAPEUTICS INC | 3 | 3 | 0.02% | 0.03% | 0.06% | Q2 2021 | Q4 2021 | 3 |
BOLT | BOLT BIOTHERAPEUTICS INC | 3 | 3 | 0.00% | 0.00% | 0.01% | Q2 2022 | Q4 2022 | 3 |
GSK PLC | 2 | 2 | 5.34% | 5.89% | 6.44% | Q3 2022 | Q4 2022 | 2 | |
NUVA | NUVASIVE INC | 2 | 2 | 1.50% | 3.49% | 5.48% | Q1 2019 | Q2 2019 | 2 |
AVXS | AVEXIS INC | 2 | 2 | 1.74% | 3.12% | 4.49% | Q4 2017 | Q1 2018 | 2 |
ABLX | ABLYNX NV | 2 | 2 | 1.45% | 3.03% | 4.61% | Q4 2017 | Q1 2018 | 2 |
INSP | INSPIRE MED SYS INC | 2 | 2 | 2.24% | 2.74% | 3.24% | Q2 2023 | Q3 2023 | 2 |
BMY | BRISTOL-MYERS SQUIBB CO | 2 | 2 | 1.93% | 2.03% | 2.13% | Q2 2021 | Q3 2021 | 2 |
ZGNX | ZOGENIX INC | 1 | 1 | 0.49% | 1.49% | 2.49% | Q2 2018 | Q2 2019 | 2 |
IWM | ISHARES TR | 1 | 1 | 0.60% | 1.19% | 1.78% | Q4 2021 | Q2 2022 | 2 |
ARKG | ARK ETF TR | 1 | 1 | 0.95% | 1.09% | 1.23% | Q2 2021 | Q4 2021 | 2 |
KRYS | KRYSTAL BIOTECH INC | 2 | 2 | 1.04% | 1.06% | 1.07% | Q2 2023 | Q3 2023 | 2 |
LNTH | LANTHEUS HLDGS INC | 2 | 2 | 0.84% | 1.05% | 1.26% | Q2 2022 | Q3 2022 | 2 |
ELEVANCE HEALTH INC | 2 | 2 | 0.66% | 0.96% | 1.26% | Q4 2022 | Q1 2023 | 2 | |
MYL | MYLAN NV | 1 | 1 | 0.82% | 0.94% | 1.07% | Q4 2018 | Q3 2020 | 2 |
AMARIN CORP PLC | 2 | 2 | 0.35% | 0.94% | 1.53% | Q4 2022 | Q1 2023 | 2 | |
EVHC | ENVISION HEALTHCARE CORP | 2 | 2 | 0.17% | 0.88% | 1.58% | Q4 2017 | Q1 2018 | 2 |
IWO | ISHARES TR | 2 | 2 | 0.03% | 0.86% | 1.68% | Q4 2021 | Q1 2022 | 2 |
PTCT | PTC THERAPEUTICS INC | 2 | 2 | 0.61% | 0.86% | 1.10% | Q1 2019 | Q2 2019 | 2 |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.62% | 0.85% | 1.08% | Q2 2018 | Q2 2022 | 2 |
THC | TENET HEALTHCARE CORP | 2 | 2 | 0.59% | 0.84% | 1.09% | Q4 2022 | Q1 2023 | 2 |
PCRX | PACIRA PHARMACEUTICALS... | 1 | 1 | 0.66% | 0.81% | 0.95% | Q4 2017 | Q2 2020 | 2 |
MDGL | MADRIGAL PHARMACEUTICA... | 2 | 2 | 0.58% | 0.73% | 0.88% | Q2 2018 | Q3 2018 | 2 |
GHDX | GENOMIC HEALTH INC | 1 | 1 | 0.63% | 0.73% | 0.83% | Q4 2018 | Q2 2019 | 2 |
CI | CIGNA CORP NEW | 2 | 2 | 0.66% | 0.69% | 0.73% | Q1 2021 | Q2 2021 | 2 |
BSTC | BIOSPECIFICS TECHNOLOG... | 2 | 2 | 0.56% | 0.64% | 0.72% | Q3 2018 | Q4 2018 | 2 |
BIIB | BIOGEN INC | 1 | 1 | 0.05% | 0.60% | 1.16% | Q2 2021 | Q3 2022 | 2 |
AMN | AMN HEALTHCARE SVCS INC | 2 | 2 | 0.08% | 0.55% | 1.03% | Q2 2021 | Q3 2021 | 2 |
HAE | HAEMONETICS CORP | 2 | 2 | 0.50% | 0.55% | 0.60% | Q1 2018 | Q2 2018 | 2 |
RAD | RITE AID CORP | 2 | 2 | 0.08% | 0.54% | 0.99% | Q4 2020 | Q1 2021 | 2 |
SYNH | SYNEOS HEALTH INC | 2 | 2 | 0.51% | 0.53% | 0.56% | Q4 2021 | Q1 2022 | 2 |
MOH | MOLINA HEALTHCARE INC | 2 | 2 | 0.34% | 0.44% | 0.54% | Q2 2023 | Q3 2023 | 2 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.35% | 0.43% | 0.51% | Q4 2017 | Q1 2018 | 2 |
ALGN | ALIGN TECHNOLOGY INC | 2 | 2 | 0.38% | 0.40% | 0.43% | Q1 2020 | Q2 2020 | 2 |
WAT | WATERS CORP | 2 | 2 | 0.24% | 0.39% | 0.54% | Q2 2023 | Q3 2023 | 2 |
PLRX | PLIANT THERAPEUTICS INC | 2 | 2 | 0.23% | 0.38% | 0.53% | Q3 2022 | Q4 2022 | 2 |
FPRX | FIVE PRIME THERAPEUTIC... | 2 | 2 | 0.26% | 0.34% | 0.42% | Q4 2020 | Q1 2021 | 2 |
PTGX | PROTAGONIST THERAPEUTI... | 2 | 2 | 0.26% | 0.34% | 0.40% | Q2 2023 | Q3 2023 | 2 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.01% | 0.32% | 0.64% | Q4 2017 | Q1 2022 | 2 |
SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.18% | 0.31% | 0.44% | Q3 2018 | Q4 2019 | 2 |
SIBN | SI-BONE INC | 2 | 2 | 0.22% | 0.29% | 0.37% | Q3 2021 | Q4 2021 | 2 |
IGMS | IGM BIOSCIENCES INC | 2 | 2 | 0.14% | 0.29% | 0.44% | Q4 2019 | Q1 2020 | 2 |
ZLAB | ZAI LAB LTD | 2 | 2 | 0.13% | 0.26% | 0.40% | Q1 2023 | Q2 2023 | 2 |
AQST | AQUESTIVE THERAPEUTICS... | 2 | 2 | 0.16% | 0.26% | 0.36% | Q4 2019 | Q1 2020 | 2 |
OM | OUTSET MED INC | 2 | 2 | 0.16% | 0.26% | 0.36% | Q2 2021 | Q3 2021 | 2 |
STRO | SUTRO BIOPHARMA INC | 2 | 2 | 0.23% | 0.26% | 0.29% | Q2 2023 | Q3 2023 | 2 |
SVRA | SAVARA INC | 2 | 2 | 0.16% | 0.21% | 0.26% | Q2 2019 | Q3 2019 | 2 |
SRDX | SURMODICS INC | 2 | 2 | 0.20% | 0.21% | 0.21% | Q4 2020 | Q1 2021 | 2 |
PRTK | PARATEK PHARMACEUTICAL... | 2 | 2 | 0.11% | 0.18% | 0.24% | Q1 2023 | Q2 2023 | 2 |
PGNY | PROGYNY INC | 2 | 2 | 0.16% | 0.18% | 0.20% | Q4 2021 | Q1 2022 | 2 |
AHAC | ALPHA HEALTHCARE ACQUI... | 2 | 2 | 0.14% | 0.17% | 0.20% | Q1 2021 | Q2 2021 | 2 |
XENT | INTERSECT ENT INC | 2 | 2 | 0.12% | 0.16% | 0.20% | Q1 2021 | Q2 2021 | 2 |
HSTM | HEALTHSTREAM INC | 2 | 2 | 0.14% | 0.15% | 0.15% | Q2 2021 | Q3 2021 | 2 |
XGN | EXAGEN INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q4 2020 | Q1 2021 | 2 |
BDTX | BLACK DIAMOND THERAPEU... | 2 | 2 | 0.08% | 0.13% | 0.18% | Q2 2023 | Q3 2023 | 2 |
MRTX | MIRATI THERAPEUTICS INC | 2 | 2 | 0.12% | 0.13% | 0.14% | Q3 2021 | Q4 2021 | 2 |
ZYME | ZYMEWORKS INC | 1 | 1 | 0.03% | 0.11% | 0.20% | Q2 2020 | Q4 2020 | 2 |
MYO | MYOMO INC | 2 | 2 | 0.07% | 0.10% | 0.12% | Q3 2021 | Q4 2021 | 2 |
AL | AIR LEASE CORP | 2 | 2 | 0.08% | 0.10% | 0.11% | Q1 2020 | Q2 2020 | 2 |
LCI | LANNET INC | 2 | 2 | 0.04% | 0.09% | 0.14% | Q3 2020 | Q4 2020 | 2 |
LOGC | LOGICBIO THERAPEUTICS INC | 2 | 2 | 0.04% | 0.08% | 0.11% | Q3 2021 | Q4 2021 | 2 |
CCRN | CROSS CTRY HEALTHCARE INC | 2 | 2 | 0.03% | 0.03% | 0.03% | Q2 2021 | Q3 2021 | 2 |
QTNT | QUOTIENT LTD | 2 | 2 | 0.02% | 0.03% | 0.03% | Q4 2017 | Q1 2018 | 2 |
OSUR | ORASURE TECHNOLOGIES INC | 1 | 1 | 2.54% | 2.54% | 2.54% | Q3 2020 | Q3 2020 | 1 |
MYL | MYLAN N V | 1 | 1 | 2.35% | 2.35% | 2.35% | Q4 2018 | Q4 2018 | 1 |
MYOV | MYOVANT SCIENCES LTD | 1 | 1 | 2.15% | 2.15% | 2.15% | Q2 2020 | Q2 2020 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 1.43% | 1.43% | 1.43% | Q1 2019 | Q1 2019 | 1 |
OGN | ORGANON & CO | 1 | 1 | 1.41% | 1.41% | 1.41% | Q2 2021 | Q2 2021 | 1 |
HALEON PLC | 1 | 1 | 1.32% | 1.32% | 1.32% | Q4 2022 | Q4 2022 | 1 | |
BDX | BECTON DICKINSON & CO | 1 | 1 | 1.25% | 1.25% | 1.25% | Q1 2021 | Q1 2021 | 1 |
ATHN | ATHENAHEALTH INC | 1 | 1 | 1.16% | 1.16% | 1.16% | Q2 2018 | Q2 2018 | 1 |
MDT | MEDTRONIC PLC | 1 | 1 | 1.16% | 1.16% | 1.16% | Q3 2018 | Q3 2018 | 1 |
AMEDISYS INC | 1 | 1 | 1.15% | 1.15% | 1.15% | Q1 2023 | Q1 2023 | 1 | |
BLUE | BLUEBIRD BIO INC | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2019 | Q4 2019 | 1 |
XLV | SELECT SECTOR SPDR TR | 1 | 1 | 1.10% | 1.10% | 1.10% | Q2 2020 | Q2 2020 | 1 |
ABCM | ABCAM PLC | 1 | 1 | 1.02% | 1.02% | 1.02% | Q2 2023 | Q2 2023 | 1 |
OMCL | OMNICELL COM | 1 | 1 | 0.99% | 0.99% | 0.99% | Q2 2021 | Q2 2021 | 1 |
ZBH | ZIMMER BIOMET HLDGS INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q4 2017 | Q4 2017 | 1 |
AXGN | AXOGEN INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q4 2017 | Q4 2017 | 1 |
R1 RCM INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q2 2022 | Q2 2022 | 1 | |
WMGI | WRIGHT MED GROUP N V | 1 | 1 | 0.85% | 0.85% | 0.85% | Q3 2018 | Q3 2018 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.82% | 0.82% | 0.82% | Q1 2021 | Q1 2021 | 1 |
IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 0.77% | 0.77% | 0.77% | Q1 2019 | Q1 2019 | 1 |
LOXO | LOXO ONCOLOGY INC | 1 | 1 | 0.76% | 0.76% | 0.76% | Q4 2018 | Q4 2018 | 1 |
IBB | ISHARES TR | 1 | 1 | 0.73% | 0.73% | 0.73% | Q3 2023 | Q3 2023 | 1 |
TLT | ISHARES TR | 1 | 1 | 0.70% | 0.70% | 0.70% | Q3 2023 | Q3 2023 | 1 |
ISEE | IVERIC BIO INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q4 2022 | Q4 2022 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.64% | 0.64% | 0.64% | Q1 2021 | Q1 2021 | 1 |
TIP | ISHARES TR | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2021 | Q2 2021 | 1 |
IMMU | IMMUNOMEDICS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2018 | Q2 2018 | 1 |
MRSN | MERSANA THERAPEUTICS INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2020 | Q3 2020 | 1 |
HYG | ISHARES TR | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2023 | Q3 2023 | 1 |
GNMK | GENMARK DIAGNOSTICS INC | 1 | 1 | 0.54% | 0.54% | 0.54% | Q1 2020 | Q1 2020 | 1 |
ALT | ALTIMMUNE INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q4 2020 | Q4 2020 | 1 |
2SEVENTY BIO INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2023 | Q3 2023 | 1 | |
CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2019 | Q1 2019 | 1 |
VREX | VAREX IMAGING CORP | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2017 | Q4 2017 | 1 |
EWT | ISHARES INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2022 | Q1 2022 | 1 |
CERN | CERNER CORP | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2021 | Q4 2021 | 1 |
NVAX | NOVAVAX INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2021 | Q1 2021 | 1 |
TSHA | TAYSHA GENE THERAPIES INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2023 | Q3 2023 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.45% | 0.45% | 0.45% | Q4 2022 | Q4 2022 | 1 |
TDOC | TELADOC HEALTH INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2021 | Q2 2021 | 1 |
CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 0.44% | 0.44% | 0.44% | Q1 2019 | Q1 2019 | 1 |
OPCH | OPTION CARE HEALTH INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2021 | Q2 2021 | 1 |
VAPO | VAPOTHERM INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2020 | Q2 2020 | 1 |
KURA | KURA ONCOLOGY INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2023 | Q2 2023 | 1 |
CLLS | CELLECTIS S A | 1 | 1 | 0.39% | 0.39% | 0.39% | Q2 2018 | Q2 2018 | 1 |
ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2018 | Q1 2018 | 1 |
ARKG | ARK ETF TR | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2021 | Q1 2021 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2022 | Q2 2022 | 1 |
VCEL | VERICEL CORP | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2018 | Q2 2018 | 1 |
LMNX | LUMINEX CORP DEL | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2021 | Q1 2021 | 1 |
KIDS | ORTHOPEDIATRICS CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2018 | Q3 2018 | 1 |
HRC | HILL-ROM HLDGS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2021 | Q3 2021 | 1 |
HRC | HILL-ROM HLDGS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2021 | Q3 2021 | 1 |
SGMO | SANGAMO THERAPEUTICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2018 | Q3 2018 | 1 |
SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2018 | Q3 2018 | 1 |
APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2021 | Q3 2021 | 1 |
KNSA | KINIKSA PHARMACEUTICAL... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2020 | Q2 2020 | 1 |
CGEM | CULLINAN ONCOLOGY INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2021 | Q2 2021 | 1 |
XRAY | DENTSPLY SIRONA INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2018 | Q3 2018 | 1 |
PNT | POINT BIOPHARMA GLOBAL... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2022 | Q3 2022 | 1 |
CDXS | CODEXIS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2019 | Q3 2019 | 1 |
ARKK | ARK ETF TR | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2022 | Q2 2022 | 1 |
PRVB | PROVENTION BIO INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2019 | Q2 2019 | 1 |
CNC | CENTENE CORP DEL | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2021 | Q1 2021 | 1 |
CIVI | CIVITAS SOLUTIONS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2017 | Q4 2017 | 1 |
IIN | INTRICON CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2018 | Q2 2018 | 1 |
EVH | EVOLENT HEALTH INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2021 | Q3 2021 | 1 |
ARDMQ | ARADIGM CORP | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2017 | Q4 2017 | 1 |
ONCT | ONCTERNAL THERAPEUTICS... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2020 | Q4 2020 | 1 |
QCP | QUALITY CARE PROPERTIE... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2018 | Q2 2018 | 1 |
IPSC | CENTURY THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2021 | Q2 2021 | 1 |
CDTX | CIDARA THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2017 | Q4 2017 | 1 |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2018 | Q3 2018 | 1 |
TARA | ARTARA THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2020 | Q1 2020 | 1 |
CDMO | AVID BIOSERVICES INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2018 | Q2 2018 | 1 |
CYAD | CELYAD SA | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2018 | Q2 2018 | 1 |
MORF | MORPHIC HLDG INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2021 | Q3 2021 | 1 |
SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2020 | Q2 2020 | 1 |
IVTY | INVUITY INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2017 | Q4 2017 | 1 |
MDXG | MIMEDX GROUP INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2018 | Q1 2018 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2020 | Q1 2020 | 1 |
SRRA | SIERRA ONCOLOGY INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2017 | Q4 2017 | 1 |
EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2021 | Q3 2021 | 1 |
OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 |
QURE | UNIQURE NV | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2020 | Q2 2020 | 1 |
GRTS | GRITSTONE BIO INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 |
SOLID BIOSCIENCES INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2020 | Q3 2020 | 1 | |
NLNK | NEWLINK GENETICS CORP | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2019 | Q3 2019 | 1 |
CATABASIS PHARMACEUTIC... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2020 | Q4 2020 | 1 | |
KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2023 | Q3 2023 | 1 |
CVM | CEL SCI CORP | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2019 | Q3 2019 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2022 | Q2 2022 | 1 |
CONFORMIS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 | |
BNR | BURNING ROCK BIOTECH LTD | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2020 | Q2 2020 | 1 |
OPNT | OPIANT PHARMACEUTICALS... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2018 | Q4 2018 | 1 |
ESTA | ESTABLISHMENT LABS HLD... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2021 | Q4 2021 | 1 |
BCRX | BIOCRYST PHARMACEUTICALS | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2019 | Q2 2019 | 1 |
KOD | KODIAK SCIENCES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2022 | Q1 2022 | 1 |
UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2021 | Q4 2021 | 1 |
MGTA | MAGENTA THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2021 | Q3 2021 | 1 |
GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
AKYA | AKOYA BIOSCIENCES INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2021 | Q3 2021 | 1 |
CHWY | CHEWY INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
FTSV | FORTY SEVEN INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2019 | Q4 2019 | 1 |
TGTX | TG THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2019 | Q4 2019 | 1 |
OSMT | OSMOTICA PHARMACEUTICA... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2020 | Q2 2020 | 1 |
BIOS | BIOSCRIP INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2019 | Q1 2019 | 1 |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 |
URGN | UROGEN PHARMA LTD | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2023 | Q2 2023 | 1 |
AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2019 | Q3 2019 | 1 |
FOMX | FOAMIX PHARMACEUTICALS... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2018 | Q3 2018 | 1 |
VCRA | VOCERA COMMUNICATIONS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2021 | Q4 2021 | 1 |
AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2019 | Q3 2019 | 1 |
IMMP | IMMUTEP LTD | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q1 2021 | 1 |
GLMD | GALMED PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2018 | Q2 2018 | 1 |
KOD | KODIAK SCIENCES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2022 | Q1 2022 | 1 |
MRVI | MARAVAI LIFESCIENCES H... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2022 | Q3 2022 | 1 |
AGTC | APPLIED GENETIC TECHNO... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2018 | Q3 2018 | 1 |
DCPH | DECIPHERA PHARMACEUTIC... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q3 2021 | 1 |
SPRO | SPERO THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2022 | Q1 2022 | 1 |
OTIC | OTONOMY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
APTOSE BIOSCIENCES INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 | |
SBTX | ARS PHARMACEUTICALS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q2 2023 | 1 |
BKD | BROOKDALE SR LIVING INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q4 2020 | 1 |
NVAX | NOVAVAX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2019 | Q1 2019 | 1 |
JYNT | JOINT CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2021 | Q4 2021 | 1 |
RDUS | RADIUS HEALTH INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
QCP | QUALITY CARE PROPERTIE... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2018 | Q2 2018 | 1 |
THIRD HARMONIC BIO INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 | |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 |
FGEN | FIBROGEN INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 |
CTLT | CATALENT INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
CNCE | CONCERT PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
VTL | VITAL THERAPIES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2018 | Q3 2018 | 1 |
FGEN | FIBROGEN INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q2 2023 | 1 |
Download |
The securities at the top of the list , including AMARIN CORP PLC, DANAHER CORPORATION, and AFFIMED N V, are the highest-conviction holdings of Eversept Partners, LP.
The conviction is calculated by counting the number of quarters a security has been reported by Eversept Partners, LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Eversept Partners, LP owns currently or has owned in the past.